Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
Transfer of shares held by Verkkokauppa.com Oyj for the payment of the remuneration to the Board of Directors - change in company’s treasury shares
-
ECARX to Report First Quarter 2024 Financial Results on May 20, 2024
-
CNH expands network connectivity with Intelsat collaboration
-
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
-
Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
-
BAORUI Applied New Security Measures to Protect Investors from Scams: Redefining Security in Crypto Trading
-
Operating hashrate increased to 9 EH/s
-
Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024
-
Gravitas Worldwide Streamlines Customs Clearance Using Descartes e-Customs™ Solution
-
Gildan Activewear Files Proxy Circular and Board of Directors Issues Letter to Shareholders
-
Award-Winning Biophilic Artist Susie Frazier to Hold Neuroinclusion Media Event at the WELL Conference on May 7
-
Reporting of transactions made by members of the Board of Directors or Executive Management or their closely associated persons
-
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
-
AirBoss Awarded Bandolier Contract Valued at up to US$45 million
-
Alberta Motor Association Insurance Company Selects IMS for Pay-As-You-Go Program
-
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for tre
-
Parsons Wins Position on $464M U.S. Army Remediation Contract
-
Sampo Group's results for January–March 2024 will be published on 7 May 2024
-
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease
-
Liberty Gold Announces C$9.5 Million Non-Brokered Private Placement Financing
-
Provident Financial Holdings Reports Third Quarter Fiscal Year 2024 Results
-
Comstock’s Physics-Based AI Investment Emerges From Stealth
-
Buildings across the nation to light up green for Mental Health Month in May
-
PRIMERICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Primerica Inc. on Behalf of Primerica Stockholders and Encourages Investors to Contact the Firm
-
Enerflex Prevails in Appeal of Mexican Labor Board Decision and Announces Timing of First Quarter Results
-
Trump Media Provides Additional Information to DJT Investors Regarding Recalling Shares
-
First Quarter Report 2024
-
Coave Therapeutics Showcases its ALIGATER™ Platform for Generating Conjugated AAV (coAAV) Vectors Exhibiting Superior Performance in Delivering Ocular Gene Therapy through the Suprachoroidal Route
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - QUANEX BUILDING PRODUCTS - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Net Asset Value(s)
-
Form 8.3 - Darktrace Plc
-
Articles of Association for Ringkjøbing Landbobank A/S
-
Implementation of capital reduction
-
Aurora Mobile Launches JPush HarmonyOS SDK Fully Compatible with HarmonyOS NEXT
-
Biden-Harris Administration Awards Record-Breaking $178 Billion in Federal Procurement Opportunities to Small Businesses
-
Mattermost Launches Strategic Integration with Parabol to Support AI-Accelerated Workflows Across Atlassian Jira and Azure AI, Enables Responsible AI for National Security Community
-
Endeavour Publishes Notice of Annual General Meeting
-
WTW and Riskonnect join forces to launch a new Risk Diagnostic Tool
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Tryg A/S – capital reduction
-
Iveco Group N.V. to present its 2024 First Quarter Results on 10th May 2024
-
FIVES - BNP Paribas Primary New Issues: NO STAB Notice
-
Man Group PLC : Form 8.3 - Tyman plc
-
Sydbank share buyback programme: transactions in week 17
-
Flash News: OKX Wallet Now Supports B² Network, Unlocks New Possibilities for Users
-
Sidetrade: 2023 Annual Report

